Glucose HK Gen.3 and 2 more
Hexokinase, Glucose. 510(k) K253490, from Roche Diagnostics (Indianapolis, IN). Product code CFR, class 2.
As of Nov 19, 2026, K253490 is an FDA 510(k) held by Roche Diagnostics, substantially equivalent on Feb 12, 2026 after 111 days, with no recalls tied to it in FDA's recall database.
- Review time: 111 days
- Recalls: 0
cobas pro integrated solutions is an automated analyzer, intended for running qualitative, semiquantitative, and quantitative clinical chemistry and immunochemistry assays as well as ion-selective measurements. Glucose HK Gen.3 is an in vitro test for the quantitative determination of glucose in human serum, plasma, urine and CSF on cobas c systems.
- Glucose HK Gen.3, ISE indirect Na for Gen.2, Elecsys TSH, cobas pro integrated solutionsK191899 · Roche Diagnostics · Aug 16, 2019
- Online Dat Ii Methadone IiK021505 · Roche Diagnostics Corp. · Jul 16, 2002
- Glucose2K252357 · Abbott Ireland · Oct 24, 2025
- cobas pure integrated solutions, Glucose HK Gen.3, ISE indirect Na for Gen.2, ONLINE DAT Methadone II, Elecsys TSHK220134 · Roche Diagnostics · Sep 16, 2022
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Oct 24, 2025
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1345
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files